- How lessons from biotechnology can help unlock the future of fusion energy
- Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
- Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
- Multiplex Assays Market Size & Share to Surpass USD 5.9 billion by 2031 | Analysis by Transparency Market Research, Inc.
- Thought Leader Engagement in Life Sciences: Refining Strategies and Tactics for Optimal KOL Engagement
- MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024
- aTyr Pharma to Present at Upcoming Investor Conferences
- Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62â¿áµˆ Annual ESPE Meeting 2024
- MacroGenics Announces Leadership Transition
- MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
